Vital symposia to close out Annual Meeting scientific program

Plan to stick around San Diego on Tuesday for the meeting’s final symposia sessions.

The 2018 AAD Annual Meeting concludes on Tuesday, Feb. 20, with two important symposia sessions.

“What’s New in Dermatology” (S067) provides attendees with the latest dermatologic developments over the last 15 months. Speakers will address updates in:

  • Infectious disease
  • Skin of color
  • Surgical dermatology
  • Cosmetic dermatology
  • Pediatric dermatology
  • Dermatopathology
  • Medical dermatologic therapy

In advance of the meeting, session director Mark Lebwohl, MD, shared a sneak peek on treatment advancements for common conditions, such as psoriasis.

“Multiple new biologics have been introduced in the past year,” Dr. Lebwohl said. “The newest agents target cytokines called IL-17 and IL-23. The ones that block IL-17 are very fast, appear to be quite safe, and are highly effective. There are patients who are born with deficiencies in IL-17, and the only thing they appear to get is yeast infections. That’s what we saw in the clinical trials of these agents, and it is the only side effect that has emerged consistently. The first IL-23 was introduced only a few months ago. It has proven to be very effective even though it requires far fewer injections than previous therapies. We anticipate several additional anti-IL-23 antibodies to be introduced in the next year or two.”

Building on “what’s new,” the panel of speakers in “Therapeutic and Diagnostic Pearls” (S068) will share evidence from peer-reviewed literature as well as outcomes from personal experience. Attendees can gain valuable insights on a wide range of subjects that can be incorporated into their practices. Uncover pearls on the following topics:

  • Skin of color
  • Autoimmune skin diseases
  • Pediatric dermatology
  • Dermato-oncology
  • Neutrophilic dermatoses
  • Dermatopathology
  • Inpatient consultative dermatology

These popular symposia are available to all Annual Meeting attendees and require no advance tickets.


Return to index